Skip to main content
. 2019 May 27;19:147. doi: 10.1186/s12877-019-1164-5

Table 4.

Disease entities

Total Poland France Germany Test result p < 0.05
mean values percentage mean values percentage mean values percentage mean values percentage
Number of patients 570 100 190 33.33 190 33.33 190 33.33
Heart failure 554 97.19 196 103.16 171 90.00 187 98.39 0.469
Hypertension 317 55.61 103 54.21 108 56.84 106 55.78 0.741
Dementia 313 54.85 95 50.00 113 59.47 105 55.25 0.002a
Depression 276 48.50 109 57.37 80 42.11 87 45.78 0.701
Osteoporosis 241 42.45 79 41.58 82 43.16 81 42.63 0.495
General atherosclerosis 186 32.63 96 50.53 28 14.74 62 32.63 0.000a
Neoplastic disease 145 25.53 28 14.73 69 36.32 48 25.26 0.000a
Diabetes 123 21.52 49 25.79 33 21.58 41 21.57 0.077
Degenerative joint disease 120 21.05 64 33.68 16 8.42 40 21.05 0.000a
Thyroid gland diseases 76 13.42 16 8.42 35 18.42 25 13.15 0.004a
Condition after femoral bone fracture 64 11.22 26 13.68 17 8.95 21 11.05 0.145
Multiple sclerosis 52 9.12 18 9.47 17 8.95 17 8.95 0.859
Neurosis 48 8.42 26 13.68 6 3.16 16 8.42 0.000a
Condition after cholecystectomy 42 7.37 14 7.37 14 7.37 14 7.37 1.000
Myocardial infarction 36 6.32 10 5.26 14 7.37 12 6.31 0.400
Hydrocephalus 35 6.14 14 7.37 9 4.74 12 6.31 0.283
Parkinson’s disease 33 5.79 12 6.32 10 5.26 11 5.78 0.661

aStatistically significant values

HHS Vulnerability Disclosure